Lv3
233 积分 2021-07-29 加入
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
2天前
已完结
Bispecific T-cell engagers (BiTE): a review of tarlatamab in small cell lung cancer
3天前
已完结
Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trial
1个月前
已完结
Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trial
1个月前
已完结
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis
1个月前
已完结
A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) in gastric or gastroesophageal junction adenocarcinoma (G/GEJA): Trial in progress
1个月前
已完结
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
7个月前
已完结
Trends in target novelty in oncology R&D
7个月前
已关闭
Trends in target novelty in oncology R&D
7个月前
已完结
Claudin 18.2 as a novel therapeutic target
8个月前
已完结
皖公网安备34019202002308
